(en) Groupe du South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT), « Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial », The Lancet, vol. 366, no 9487, , p. 717-725 (PMID16125588, DOI10.1016/S0140-6736(05)67176-0, lire en ligne)
(en) Arjen M. Dondorp, Caterina I. Fanello, Ilse C. E. Hendriksen, Ermelinda Gomes, Nicholas J. White et al. pour le groupe African Quinine Artesunate Malaria Trial (AQUAMAT), « Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial », The Lancet, vol. 376, no 9753, , p. 1647-57. (PMID21062666, PMCIDPMC3033534, DOI10.1016/S0140-6736(10)61924-1, lire en ligne)
(en) Katharine L. Jones, Sarah Donegan et David G. Lalloo, « Artesunate versus quinine for treating severe malaria », The Cochrane Database of Systematic Reviews, vol. 4, , CD005967. (PMID17943870, DOI10.1002/14651858.CD005967.pub2, lire en ligne)
(en) Denis Boulanger, Yemou Dieng, Badara Cisse, Franck Remoue, Francois Simondon et al., « Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks », Transactions of the Royal Society of Tropical Medicine & Hygiene, vol. 101, no 2, , p. 113-6. (PMID16765398, DOI10.1016/j.trstmh.2006.03.003, lire en ligne)
(en) Robert L. Clark, « Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients », Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 94, no 2, , p. 61-75 (DOI10.1002/bdra.22868, lire en ligne)
(en) Thierry Rolling, Tsiri Agbenyega, Saadou Issifou, Ayola Akim Adegnika, Justice Sylverken, Dorothee Spahlinger, Daniel Ansong, Sascha J. Z. Löhr, Gerd D. Burchard, Jürgen May, Benjamin Mordmüller, Sanjeev Krishna, Peter G. Kremsner et Jakob P. Cramer, « Delayed Hemolysis After Treatment With Parenteral Artesunate in African Children With Severe Malaria—A Double-center Prospective Study », Journal of Infectious Diseases, (PMID24376273, DOI10.1093/infdis/jit841, lire en ligne)
(en) Robert L. Clark, « Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester », Reproductive Toxicology, vol. 28, no 3, , p. 285-296 (PMID19447170, DOI10.1016/j.reprotox.2009.05.002, lire en ligne)
(en) Wanxing Eugene Ho, Yong-Jiang Xu, Fengguo Xu, Chang Cheng, Hong Yong Peh, Shao-Min Huang, Steven R. Tannenbaum, Choon Nam Ong, W. S. Fred Wong, « Anti-malarial drug artesunate restores metabolic changes in experimental allergic asthmaAnti-malarial drug artesunate restores metabolic changes in experimental allergic asthma », Metabolomics, (DOI10.1007/s11306-014-0699-x, résumé).
(en) Groupe du South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT), « Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial », The Lancet, vol. 366, no 9487, , p. 717-725 (PMID16125588, DOI10.1016/S0140-6736(05)67176-0, lire en ligne)
(en) Arjen M. Dondorp, Caterina I. Fanello, Ilse C. E. Hendriksen, Ermelinda Gomes, Nicholas J. White et al. pour le groupe African Quinine Artesunate Malaria Trial (AQUAMAT), « Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial », The Lancet, vol. 376, no 9753, , p. 1647-57. (PMID21062666, PMCIDPMC3033534, DOI10.1016/S0140-6736(10)61924-1, lire en ligne)
(en) Katharine L. Jones, Sarah Donegan et David G. Lalloo, « Artesunate versus quinine for treating severe malaria », The Cochrane Database of Systematic Reviews, vol. 4, , CD005967. (PMID17943870, DOI10.1002/14651858.CD005967.pub2, lire en ligne)
(en) Denis Boulanger, Yemou Dieng, Badara Cisse, Franck Remoue, Francois Simondon et al., « Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks », Transactions of the Royal Society of Tropical Medicine & Hygiene, vol. 101, no 2, , p. 113-6. (PMID16765398, DOI10.1016/j.trstmh.2006.03.003, lire en ligne)
(en) Thierry Rolling, Tsiri Agbenyega, Saadou Issifou, Ayola Akim Adegnika, Justice Sylverken, Dorothee Spahlinger, Daniel Ansong, Sascha J. Z. Löhr, Gerd D. Burchard, Jürgen May, Benjamin Mordmüller, Sanjeev Krishna, Peter G. Kremsner et Jakob P. Cramer, « Delayed Hemolysis After Treatment With Parenteral Artesunate in African Children With Severe Malaria—A Double-center Prospective Study », Journal of Infectious Diseases, (PMID24376273, DOI10.1093/infdis/jit841, lire en ligne)
(en) Robert L. Clark, « Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester », Reproductive Toxicology, vol. 28, no 3, , p. 285-296 (PMID19447170, DOI10.1016/j.reprotox.2009.05.002, lire en ligne)
oxfordjournals.org
trstmh.oxfordjournals.org
(en) Denis Boulanger, Yemou Dieng, Badara Cisse, Franck Remoue, Francois Simondon et al., « Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks », Transactions of the Royal Society of Tropical Medicine & Hygiene, vol. 101, no 2, , p. 113-6. (PMID16765398, DOI10.1016/j.trstmh.2006.03.003, lire en ligne)
jid.oxfordjournals.org
(en) Thierry Rolling, Tsiri Agbenyega, Saadou Issifou, Ayola Akim Adegnika, Justice Sylverken, Dorothee Spahlinger, Daniel Ansong, Sascha J. Z. Löhr, Gerd D. Burchard, Jürgen May, Benjamin Mordmüller, Sanjeev Krishna, Peter G. Kremsner et Jakob P. Cramer, « Delayed Hemolysis After Treatment With Parenteral Artesunate in African Children With Severe Malaria—A Double-center Prospective Study », Journal of Infectious Diseases, (PMID24376273, DOI10.1093/infdis/jit841, lire en ligne)
(en) Robert L. Clark, « Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester », Reproductive Toxicology, vol. 28, no 3, , p. 285-296 (PMID19447170, DOI10.1016/j.reprotox.2009.05.002, lire en ligne)
(en) Wanxing Eugene Ho, Yong-Jiang Xu, Fengguo Xu, Chang Cheng, Hong Yong Peh, Shao-Min Huang, Steven R. Tannenbaum, Choon Nam Ong, W. S. Fred Wong, « Anti-malarial drug artesunate restores metabolic changes in experimental allergic asthmaAnti-malarial drug artesunate restores metabolic changes in experimental allergic asthma », Metabolomics, (DOI10.1007/s11306-014-0699-x, résumé).
thelancet.com
(en) Groupe du South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT), « Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial », The Lancet, vol. 366, no 9487, , p. 717-725 (PMID16125588, DOI10.1016/S0140-6736(05)67176-0, lire en ligne)
(en) Arjen M. Dondorp, Caterina I. Fanello, Ilse C. E. Hendriksen, Ermelinda Gomes, Nicholas J. White et al. pour le groupe African Quinine Artesunate Malaria Trial (AQUAMAT), « Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial », The Lancet, vol. 376, no 9753, , p. 1647-57. (PMID21062666, PMCIDPMC3033534, DOI10.1016/S0140-6736(10)61924-1, lire en ligne)
(en) Katharine L. Jones, Sarah Donegan et David G. Lalloo, « Artesunate versus quinine for treating severe malaria », The Cochrane Database of Systematic Reviews, vol. 4, , CD005967. (PMID17943870, DOI10.1002/14651858.CD005967.pub2, lire en ligne)
(en) Robert L. Clark, « Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients », Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 94, no 2, , p. 61-75 (DOI10.1002/bdra.22868, lire en ligne)